Trial Profile
Sitagliptin Versus Sulphonylurea Based Treatments in Muslim Patients With Type 2 Diabetes During Ramadan.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 13 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Jan 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.
- 20 Oct 2008 New trial record.